Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2008, Vol. 112, No. 10, pp. 4109-4116.
Prepublished online as a Blood First Edition Paper on September 10, 2008; DOI 10.1182/blood-2008-02-139527.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-02-139527v1
112/10/4109    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tassi, I.
Right arrow Articles by Colonna, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tassi, I.
Right arrow Articles by Colonna, M.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

NK cell–activating receptors require PKC-{theta} for sustained signaling, transcriptional activation, and IFN-{gamma} secretion

Ilaria Tassi1, Marina Cella1, Rachel Presti1, Angela Colucci1, Susan Gilfillan1, Dan R. Littman2, and Marco Colonna1

1 Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; and 2 Molecular Pathogenesis Program, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, NY

Natural killer (NK) cell sense virally infected cells and tumor cells through multiple cell surface receptors. Many NK cell–activating receptors signal through immunoreceptor tyrosine–based activation motif (ITAM)–containing adapters, which trigger both cytotoxicy and secretion of interferon-gamma (IFN-{gamma}). Within the ITAM pathway, distinct signaling intermediates are variably involved in cytotoxicity and/or IFN-{gamma} secretion. In this study, we have evaluated the role of protein kinase C-{theta} (PKC-{theta}) in NK-cell secretion of lytic mediators and IFN-{gamma}. We found that engagement of NK-cell receptors that signal through ITAMs results in prompt activation of PKC-{theta}. Analyses of NK cells from PKC-{theta}–deficient mice indicated that PKC-{theta} is absolutely required for ITAM-mediated IFN-{gamma} secretion, whereas it has no marked influence on the release of cytolytic mediators. Moreover, we found that PKC-{theta} deficiency preferentially impairs sustained extracellular-regulated kinase signaling as well as activation of c-Jun N-terminal kinase and the transcription factors AP-1 and NFAT but does not affect activation of NF-{kappa}B. These results indicate that NK cell–activating receptors require PKC-{theta} to generate sustained intracellular signals that reach the nucleus and promote transcriptional activation, ultimately inducing IFN-{gamma} production.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. I. Aguilo, J. Garaude, J. Pardo, M. Villalba, and A. Anel
Protein Kinase C-{theta} Is Required for NK Cell Activation and In Vivo Control of Tumor Progression
J. Immunol., February 15, 2009; 182(4): 1972 - 1981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kumar, J. Hosse, C. von Toerne, E. Noessner, and P. J. Nelson
JNK MAPK Pathway Regulates Constitutive Transcription of CCL5 by Human NK Cells through SP1
J. Immunol., January 15, 2009; 182(2): 1011 - 1020.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020